Fig. 2: Effect sizes (Cohen’s d) of the difference in rsFC between ASD and NT (placebo condition). | Neuropsychopharmacology

Fig. 2: Effect sizes (Cohen’s d) of the difference in rsFC between ASD and NT (placebo condition).

From: Random forest and Shapley Additive exPlanations predict oxytocin targeted effects on brain functional networks involved in salience and sensorimotor processing, in a randomized clinical trial in autism

Fig. 2

Darker colors and lighter colors depict stronger differences. Darker colors signify strong effect sizes for ASD to have hypoconnectivity relative to NT while brighter colors signify strong effect sizes for ASD subject to have hyperconnectivity compared to NT.

Back to article page